KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Gross Profit (2017 - 2025)

Cardlytics (CDLX) has disclosed Gross Profit for 9 consecutive years, with $48.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit fell 22.48% year-over-year to $48.6 million, compared with a TTM value of $193.8 million through Dec 2025, down 14.12%, and an annual FY2025 reading of $193.8 million, down 14.12% over the prior year.
  • Gross Profit was $48.6 million for Q4 2025 at Cardlytics, up from $44.2 million in the prior quarter.
  • Across five years, Gross Profit topped out at $75.1 million in Q4 2023 and bottomed at $40.0 million in Q1 2021.
  • Average Gross Profit over 5 years is $54.8 million, with a median of $53.5 million recorded in 2022.
  • The sharpest move saw Gross Profit soared 134.55% in 2021, then decreased 22.48% in 2025.
  • Year by year, Gross Profit stood at $71.1 million in 2021, then decreased by 7.56% to $65.7 million in 2022, then rose by 14.28% to $75.1 million in 2023, then dropped by 16.52% to $62.7 million in 2024, then fell by 22.48% to $48.6 million in 2025.
  • Business Quant data shows Gross Profit for CDLX at $48.6 million in Q4 2025, $44.2 million in Q3 2025, and $51.9 million in Q2 2025.